Aquestive Therapeutics Announces Leadership Changes

Aquestive Therapeutics has announced a new role for Lori J. Braender and the appointment of Thomas A. Zalewski as its Chief Legal Officer and Chief Compliance Officer. Zalewski, previously a Partner at Day Pitney LLP, will assume his new responsibilities effective April 2, 2026. These strategic leadership changes are aimed at strengthening the company's legal and compliance functions. Such appointments are crucial for navigating the complex regulatory landscape inherent in the pharmaceutical and biotechnology sectors.